These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31182257)
1. Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now? Suaifan GARY; Mohammed AAM Bioorg Med Chem; 2019 Jul; 27(14):3005-3060. PubMed ID: 31182257 [TBL] [Abstract][Full Text] [Related]
2. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin. Kocsis B; Domokos J; Szabo D Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369 [TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. Suaifan GARY; Mohammed AAM; Alkhawaja BA Molecules; 2022 Mar; 27(5):. PubMed ID: 35268759 [TBL] [Abstract][Full Text] [Related]
4. Current Trends and Future Directions of Fluoroquinolones. Mohammed HHH; Abuo-Rahma GEAA; Abbas SH; Abdelhafez EMN Curr Med Chem; 2019; 26(17):3132-3149. PubMed ID: 29446718 [TBL] [Abstract][Full Text] [Related]
5. Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. Kocsis B; Gulyás D; Szabó D Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943718 [TBL] [Abstract][Full Text] [Related]
6. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
13. Recent updates of fluoroquinolones as antibacterial agents. Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine. Purkayastha N; Capone S; Beck AK; Seebach D; Leeds J; Thompson K; Moser HE Chem Biodivers; 2015 Feb; 12(2):179-93. PubMed ID: 25676502 [TBL] [Abstract][Full Text] [Related]
15. Delafloxacin for the treatment of respiratory and skin infections. Bassetti M; Della Siega P; Pecori D; Scarparo C; Righi E Expert Opin Investig Drugs; 2015 Mar; 24(3):433-42. PubMed ID: 25604710 [TBL] [Abstract][Full Text] [Related]
16. The fluoroquinolones. Walker RC Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety. Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513 [TBL] [Abstract][Full Text] [Related]